Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy

Status: Recruiting
Location: See location...
Intervention Type: Device, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to learn about the effect of video-game based rehabilitation exercise for patients with knee osteoarthritis. The main question the study aims to answer is: do patients who exercise with the game have better functional outcomes and engagement compared to patients who do conventional exercise? Participants will complete 10 weeks of physical therapy exercise sessions that focus on quadriceps strengthening. Two sessions per week will be conducted in the clinic, and one session will be conducted at home each week. The interventional group will conduct all exercises using the KneeBRIGHT EMG sensors and game software. The control group will conduct all exercises following a standard physical therapy regimen. Researchers will compare knee function and engagement between the group who uses the game, and the group who does conventional exercise.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 75
Healthy Volunteers: f
View:

• diagnosis via x-ray, with a score of at least 2 (out of 4) on the Kellgren-Lawrence OA scoring system; independent ambulation without assistive device

Locations
United States
North Carolina
University of North Carolina Chapel Hill
RECRUITING
Chapel Hill
Contact Information
Primary
Eileen Krepkovich, MS
krepkovich@barronassociates.com
4349731215
Time Frame
Start Date: 2024-09-04
Estimated Completion Date: 2025-12
Participants
Target number of participants: 60
Treatments
Experimental: KneeBRIGHT Group
The interventional group will conduct all exercises during the 10-week therapy regimen using the KneeBRIGHT electromyogram sensors and game software.
Active_comparator: Control Group
The control group will conduct all exercises following a standard physical therapy regimen.
Related Therapeutic Areas
Sponsors
Leads: Barron Associates, Inc.
Collaborators: University of North Carolina, Chapel Hill

This content was sourced from clinicaltrials.gov

Similar Clinical Trials